Blue Line Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$957K Buy
11,090
+189
+2% +$16.8K 0.74% 42
2026
Q2
$986K Buy
10,901
+1,516
+16% +$127K 0.82% 40
2026
Q1
$752K Buy
9,385
+605
+7% +$49.9K 0.85% 42
2025
Q4
$748K Buy
+8,780
New +$721K 0.88% 40

Other funds holding EW

Blue Line Capital's EW Position: Q3 2026 in Review

Blue Line Capital increased its Edwards Lifesciences (EW) stake by 1.7% in Q3 2026, buying an estimated $16.8K and bringing the position to 11,090 shares worth $957K. The position accounts for 0.74% of the portfolio, ranked #42.

Blue Line Capital first reported a position in EW in Q4 2025 and has held it in 4 quarters since. The position peaked at $986K in Q2 2026. 1,342 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Blue Line Capital held 11,090 shares of Edwards Lifesciences worth $957K as of Q3 2026.
  • Blue Line Capital bought 189 Edwards Lifesciences shares in Q3 2026, an estimated $16.8K.
  • Edwards Lifesciences made up 0.74% of Blue Line Capital's portfolio in Q3 2026, its #42 holding.
  • Blue Line Capital first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 4 quarters since.
  • Blue Line Capital's Edwards Lifesciences position peaked at $986K in Q2 2026.
  • 1,342 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Blue Line Capital's 13F filing for Q3 2026, filed 4 Nov 2026.